How much money can I get from the Chantix settlement?

Pfizer is paying $44,000,000 to resolve the claims. After attorneys' fees, costs, notice and administration expenses, and any service awards, up to 20% of the net fund is allocated to consumers and the remainder to third-party payors. Each consumer who files a valid claim receives a pro rata share based on the out-of-pocket amount they paid for Chantix, and no consumer's payment will exceed the total they paid. The exact per-person amount depends on how many valid claims are filed.

Do I need proof or receipts to file a Chantix claim?

No documentation is required at the time you file. The consumer Claim Form asks you to state the number of Chantix prescriptions you purchased and your total out-of-pocket cost during the class period; there is no Notice ID or Claim ID to enter. However, the Settlement Administrator may request proof later, so keep records such as an explanation of benefits, pharmacy records, or prescription records showing you paid for Chantix.

What is the deadline to file a Chantix claim?

Claim Forms must be submitted online or postmarked by September 14, 2026. The same date is the deadline to exclude yourself from or object to the Settlement. The Court's Final Approval Hearing is scheduled for October 13, 2026.

What was wrong with Chantix?

Plaintiffs alleged that Pfizer's stop-smoking drug Chantix (varenicline) contained an undisclosed nitrosamine impurity and that Pfizer misrepresented its adherence to current Good Manufacturing Practices. Pfizer denies any wrongdoing and denies violating any law but agreed to the Settlement to avoid the cost and uncertainty of continued litigation. The Court has not decided who is right.

Chantix $44M Settlement: Claim by September 14, 2026

Q: Who qualifies for the Chantix settlement?

You are a Settlement Class Member if you paid any amount of money for retail purchases of Chantix in the United States and its territories from September 29, 2015 through September 17, 2021. Both individual consumers and third-party payors (such as health plans and insurers) are included. Pfizer employees and officers, government actors, anyone whose only purchases fell outside the class period, and anyone who previously opted out are excluded.

Published July 15, 2026

Updated August 31, 2026

People who paid out of pocket for retail Chantix in the United States between September 29, 2015 and September 17, 2021 may qualify to claim a pro rata cash share of the $44 million settlement, with no Notice ID or receipts needed to file. Claims close September 14, 2026, and prescriptions and costs are self-reported.

Pfizer will pay $44 million to resolve claims that its stop-smoking drug Chantix contained an undisclosed nitrosamine impurity. Pfizer denies any wrongdoing.

By Steve Levine

Editor-in-Chief

What Is This Settlement About?

Pfizer, Inc. has agreed to pay $44,000,000 to settle a putative class action claiming that its branded stop-smoking drug Chantix (varenicline) contained an undisclosed nitrosamine impurity and that Pfizer misrepresented its adherence to current Good Manufacturing Practices in making the drug. The case is In re Chantix (Varenicline) Marketing, Sales Practices and Products Liability Litigation (No. II), No. 22-MD-3050 (KPF), before Judge Katherine Polk Failla in the U.S. District Court for the Southern District of New York.

Pfizer believes it did nothing wrong and denies violating any law. It agreed to the Settlement to avoid the uncertainties and expenses of continued litigation, and the Court has not decided who is right. The Court granted preliminary approval on June 1, 2026, and notice went out to the class in July 2026. Claims are now open.

Free settlement alerts

Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.

Status Claims Open Preliminarily approved June 1, 2026 · final approval hearing October 13, 2026

Claim Deadline September 14, 2026 Submit online or postmark by this date · same date to exclude or object

Estimated Payout Pro rata cash Based on what you paid out of pocket for Chantix · consumer pool is up to 20% of the net $44M fund

Proof Required No Self-report your prescriptions & out-of-pocket cost · no Notice ID or Claim ID · keep pharmacy records in case the administrator asks

Who Qualifies?

The Settlement Class includes all individuals and third-party payors who paid any amount of money for retail purchases of Chantix in the United States and its territories from September 29, 2015 through September 17, 2021. If you filled a Chantix prescription and paid anything toward it during that window — a copay, coinsurance, or a deductible amount — you are covered.

Several groups are excluded and cannot file a claim, even if they otherwise fit the definition: any officer, director, manager, or employee of Pfizer; government agencies or governmental actors, including any state Attorney General office; anyone whose only Chantix purchases fell before September 29, 2015 or after September 17, 2021; and anyone who previously opted out of the Settlement Class in this case.

The Settlement covers only Pfizer-brand Chantix, not generic varenicline made by other manufacturers. There are two ways to claim: an Individual Consumer Claim Form for people who paid out of pocket, and a separate Third-Party Payor Claim Form for health plans, insurers, and other entities that paid or reimbursed for Chantix. Use the form that matches who you are.

How Much Can You Get?

Pfizer is paying a total of $44,000,000. After the Court deducts attorneys' fees, litigation expenses, notice and administration costs, and any class representative service awards, the remaining net fund is split: up to 20% goes to the consumer class, and the rest goes to third-party payors.

Each consumer who submits a valid claim receives a pro rata share of the consumer pool, calculated from the out-of-pocket amount they paid for Chantix during the class period. No consumer's payment will be more than the total they actually paid for the drug. Third-party payors are paid pro rata from the remainder based on their qualifying, documented payments. Because payments are pro rata, the exact per-person amount will not be known until all valid claims are counted after the deadline.

Payments are sent digitally by default, so the claim form asks for a valid email address and mobile phone number unless you affirmatively choose another payment method.

How to File a Claim

You can file online through the official settlement website, ChantixSettlement.com, or download a paper Claim Form and mail it so it is postmarked by the deadline. Consumers should use the Consumer Claim Form; third-party payors should use the TPP Claim Form and submit supporting claims data.

On the consumer form you confirm you are a class member, then provide the number of Chantix prescriptions you purchased and your total out-of-pocket cost from September 29, 2015 through September 17, 2021. You do not need to attach documentation when you file, but the Settlement Administrator may ask for proof later — an explanation of benefits from your insurer, pharmacy records, or copies of prescription records showing you paid for Chantix. Keep those records until your payment arrives.

Your Other Options and Key Dates

If you do nothing, you will not receive a payment and you will give up your right to sue Pfizer over the claims in this case. You have until September 14, 2026 to exclude yourself (opt out) if you want to keep your right to sue, or to object if you want to tell the Court why you do not like the Settlement. The Court will hold its Final Approval Hearing on October 13, 2026 at 3:00 p.m. in Courtroom 618 of the Southern District of New York; you may attend but are not required to.

Be cautious of any website other than the official one presenting a "Chantix claim form." The Settlement is administered by A.B. Data, Ltd. under the supervision of Class Counsel, and the only official site is ChantixSettlement.com. This page is informational and is not legal advice — do not stop a prescribed medication because of a settlement.

For background on the underlying litigation — the 2021 recall and the consolidated cases that led here — see our explainer on the Chantix varenicline nitrosamine MDL. If you paid for common generic drugs in recent years, you may also qualify for the separate generic drug price-fixing settlements.

Frequently Asked Questions

Who qualifies for the Chantix settlement?

Anyone who paid any amount for retail purchases of Chantix in the United States and its territories from September 29, 2015 through September 17, 2021. Both individual consumers and third-party payors (health plans, insurers) are included. Pfizer insiders, government actors, people whose only purchases fell outside the class period, and prior opt-outs are excluded.

Do I need receipts to file?

No documentation is required when you file. You self-report the number of prescriptions and your out-of-pocket cost, and there is no Notice ID or Claim ID to enter. The Settlement Administrator may request proof later, so keep an explanation of benefits, pharmacy records, or prescription records showing you paid for Chantix.

How much will I receive?

Each valid consumer claim gets a pro rata share of the consumer pool (up to 20% of the net $44 million fund), based on what you paid out of pocket, capped at your total spend. Because it is pro rata, the exact amount depends on how many valid claims are filed.

What is the deadline?

Claim Forms must be submitted online or postmarked by September 14, 2026. That is also the deadline to opt out or object. The Final Approval Hearing is October 13, 2026.

Official Settlement Notice & Claim Form

Sources

• Official Chantix Settlement website (A.B. Data, Ltd., administrator): ChantixSettlement.com
• CourtListener — docket for In re Chantix (Varenicline)…, No. 1:22-md-03050 (S.D.N.Y.): CourtListener Docket
• U.S. Food and Drug Administration — nitrosamine in varenicline (Chantix) updates: FDA Nitrosamine / Varenicline Updates

For more class actions keep scrolling below.

Settlement Amount $44,000,000

Case Title In re Chantix (Varenicline) Marketing, Sales Practices and Products Liability Litigation (No. II)

Case Number 22-MD-3050 (KPF) · 22-MC-3050

Court U.S. District Court, S.D.N.Y. · Judge Katherine Polk Failla

Final Approval Hearing October 13, 2026 at 3:00 PM Courtroom 618 · Thurgood Marshall U.S. Courthouse, 40 Foley Square, New York

Administrator A.B. Data, Ltd.

Official Website Chantix Settlement.com